Drug intelligence / Profile preview

3-3-4 mix

Development stage: Unknown
Modality: Small Molecules
Administration: Local

Overview

The "3-3-4 mix" is a specific formulation of local anesthetic agents used for pain control during voluntary medical male circumcision. It consists of 3cc of Lignocaine 2%, 3cc of Bupivacaine 0.5%, and 4cc of water for injection. This combination aims to provide effective local anesthesia by blocking nerve impulses, thereby reducing post-operative pain.

Other names: 3-3-4 mixturelignocaine and bupivacaine mixlidocaine and bupivacaine mix3-3-4 lidocaine-bupivacaine mix

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on 3-3-4 mix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-3-4 mix.

Explore the full profile